ALB vs AYTU · rev $1.74B vs rev $66.4M
Albemarle Corp (ALB) versus Aytu BioScience Inc (AYTU) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
ALB currently screens at market cap $8.00B. AYTU currently screens at market cap $24.1M.
Not investment advice. Open the ALB and AYTU stock pages for the full models.
Not investment advice.